Plain-English translation of NCT07224607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer's Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing photobiomodulation—a special near-infrared light therapy applied to the forehead—to see if it can help improve thinking skills and memory in people with mild cognitive impairment or early dementia due to Alzheimer's disease. The light device is cleared by the FDA but is being tested here in a new way, specifically for brain health. Researchers want to learn whether the treatment improves thinking and whether it changes certain markers in the blood related to brain inflammation and damage.
Current Alzheimer's treatments have limited effectiveness, and doctors are looking for new ways to help people with memory problems. This study explores whether a non-invasive light therapy might boost blood flow and reduce inflammation in the brain, potentially slowing cognitive decline.
You likely qualify if…
You likely don't qualify if…
You would visit Cedars-Sinai weekly for light therapy sessions. During each visit, the infrared light device would be applied to your forehead for about 8 minutes (or just 5 seconds if you're in the comparison group). Before and after the treatment period, you'll complete thinking and memory tests, answer questions about your cognitive function, and provide blood samples so researchers can measure inflammation and other brain-related markers. The study tracks how your memory and thinking skills change over time.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States